3-156544421-A-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_007107.5(SSR3):āc.378T>Cā(p.Asn126Asn) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00146 in 1,584,122 control chromosomes in the GnomAD database, including 29 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0072 ( 12 hom., cov: 32)
Exomes š: 0.00084 ( 17 hom. )
Consequence
SSR3
NM_007107.5 synonymous
NM_007107.5 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.227
Genes affected
SSR3 (HGNC:11325): (signal sequence receptor subunit 3) The signal sequence receptor (SSR) is a glycosylated endoplasmic reticulum (ER) membrane receptor associated with protein translocation across the ER membrane. The SSR is comprised of four membrane proteins/subunits: alpha, beta, gamma, and delta. The first two are glycosylated subunits and the latter two are non-glycosylated subunits. This gene encodes the gamma subunit, which is predicted to span the membrane four times. [provided by RefSeq, Aug 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.55).
BP6
Variant 3-156544421-A-G is Benign according to our data. Variant chr3-156544421-A-G is described in ClinVar as [Benign]. Clinvar id is 788520.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.227 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00723 (1102/152358) while in subpopulation AFR AF= 0.0251 (1042/41588). AF 95% confidence interval is 0.0238. There are 12 homozygotes in gnomad4. There are 533 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 12 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SSR3 | NM_007107.5 | c.378T>C | p.Asn126Asn | synonymous_variant | 4/5 | ENST00000265044.7 | NP_009038.1 | |
SSR3 | NM_001308197.2 | c.417T>C | p.Asn139Asn | synonymous_variant | 4/5 | NP_001295126.1 | ||
SSR3 | NM_001308204.2 | c.222T>C | p.Asn74Asn | synonymous_variant | 4/5 | NP_001295133.1 | ||
SSR3 | NM_001308205.2 | c.222T>C | p.Asn74Asn | synonymous_variant | 4/5 | NP_001295134.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00721 AC: 1097AN: 152240Hom.: 12 Cov.: 32
GnomAD3 genomes
AF:
AC:
1097
AN:
152240
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00207 AC: 474AN: 229054Hom.: 9 AF XY: 0.00142 AC XY: 176AN XY: 123808
GnomAD3 exomes
AF:
AC:
474
AN:
229054
Hom.:
AF XY:
AC XY:
176
AN XY:
123808
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000842 AC: 1206AN: 1431764Hom.: 17 Cov.: 30 AF XY: 0.000765 AC XY: 544AN XY: 710716
GnomAD4 exome
AF:
AC:
1206
AN:
1431764
Hom.:
Cov.:
30
AF XY:
AC XY:
544
AN XY:
710716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00723 AC: 1102AN: 152358Hom.: 12 Cov.: 32 AF XY: 0.00715 AC XY: 533AN XY: 74510
GnomAD4 genome
AF:
AC:
1102
AN:
152358
Hom.:
Cov.:
32
AF XY:
AC XY:
533
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
8
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 16, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at